Chronic Back Pain Clinical Trial
Official title:
Open-Label, Post Market Study: Study the Effects of Differential Target Multiplexed Spinal Cord Stimulation (DTMâ„¢SCS) Programs in Treating Intractable Chronic Back Pain in Subjects Without Prior History of Spine Surgery
This is an open-label prospective, randomized, controlled, multi-center study comparing DTM-SCS programming approach to Conventional SCS programming approach. The purpose of this investigational study is to study the effects of Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS) in subjects with chronic, intractable pain of the trunk with or without lower limb pain, including unilateral or bilateral pain without prior history of spine surgery and refractory to conservative and surgical interventions.
This is an open-label prospective, randomized, controlled, multi-center study comparing DTM-SCS programming approach to Conventional SCS programming approach. Subjects meeting study entrance criteria will be randomized in a 1:1 ratio to one of two study treatment groups: - Test treatment group with DTM-SCS programming approach - Control treatment group with Conventional SCS programming approach Data at follow-up visits will be compared between the two treatment groups, and in reference to baseline assessments collected at the beginning of the study. There is an optional two-way crossover to the other treatment group available for all subjects who remain implanted at 6 month visit. Up to 250 subjects may be enrolled at up to 20 clinical sites in the United States in order to include an estimated 135 subjects to the point of randomization. This would allow a minimum of 100 subjects (50% in each treatment arm) to complete the 3-month endpoint. The expected total duration of this study is approximately 32 months. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01944150 -
Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis
|
N/A | |
Recruiting |
NCT05220202 -
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
|
N/A | |
Active, not recruiting |
NCT05203770 -
Adaptations of the Brain in Chronic Pain With Opioid Exposure I
|
||
Withdrawn |
NCT04082715 -
Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
|
Phase 2 | |
Completed |
NCT04307446 -
Immersive Virtual Reality and Chronic Back Pain
|
N/A | |
Completed |
NCT03896035 -
Improving Outcomes for Older Veterans With Chronic Back Pain and Depression
|
N/A | |
Recruiting |
NCT05994118 -
Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports
|
N/A | |
Active, not recruiting |
NCT03312010 -
Tsunami DRG High Frequency Stimulation Study
|
N/A | |
Recruiting |
NCT06453109 -
Focused Ultrasound for the Complex Patient
|
N/A | |
Completed |
NCT05167214 -
The Acute Effect Of Different Kinesiological Tape
|
N/A | |
Recruiting |
NCT06288282 -
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
|
||
Recruiting |
NCT04270617 -
The Effect of Yoga Practice on Chronic Back Pain
|
N/A | |
Withdrawn |
NCT01631513 -
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
|
Phase 4 | |
Completed |
NCT01766973 -
Decoding Chronic Pain With fMRI
|
||
Completed |
NCT02375633 -
Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
|
Phase 3 | |
Recruiting |
NCT06406699 -
Feasibility and Acceptability of Group Pain Reprocessing Therapy for Veterans With Chronic Neck/Back Pain
|
N/A |